Q7TN58
Gene name |
Tmc8 (Ever2) |
Protein name |
Transmembrane channel-like protein 8 |
Names |
Epidermodysplasia verruciformis protein 2 homolog |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:217356 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q7TN58
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q7TN58-F1 | Predicted | AlphaFoldDB |
31 variants for Q7TN58
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs1134447310 | 7 | V>M | No | EVA | |
| rs237176835 | 18 | S>P | No | EVA | |
| rs257820219 | 76 | V>M | No | EVA | |
| rs214633597 | 140 | V>I | No | EVA | |
| rs3389219803 | 152 | K>E | No | EVA | |
| rs248301031 | 154 | R>S | No | EVA | |
| rs263763065 | 159 | S>G | No | EVA | |
| rs3389224015 | 164 | Q>H | No | EVA | |
| rs241350745 | 195 | A>V | No | EVA | |
| rs3389236098 | 215 | V>I | No | EVA | |
| rs212272399 | 239 | G>S | No | EVA | |
| rs3389216744 | 249 | K>I | No | EVA | |
| rs3389216735 | 271 | I>T | No | EVA | |
| rs224384655 | 284 | R>H | No | EVA | |
| rs240177927 | 285 | V>M | No | EVA | |
| rs3389221646 | 292 | T>A | No | EVA | |
| rs3413061716 | 361 | V>D | No | EVA | |
| rs3389195763 | 386 | L>M | No | EVA | |
| rs3389209186 | 392 | F>S | No | EVA | |
| rs3389232888 | 424 | E>G | No | EVA | |
| rs28259561 | 460 | F>C | No | EVA | |
| rs3389155464 | 473 | F>I | No | EVA | |
| rs3389223974 | 484 | A>V | No | EVA | |
| rs3389216420 | 504 | S>N | No | EVA | |
| rs3389183304 | 557 | I>N | No | EVA | |
| rs28259556 | 614 | V>I | No | EVA | |
| rs3389216729 | 622 | S>F | No | EVA | |
| rs3389231024 | 628 | A>T | No | EVA | |
| rs3389155532 | 651 | S>L | No | EVA | |
| rs3389221293 | 674 | F>S | No | EVA | |
| rs28259550 | 685 | G>D | No | EVA |
No associated diseases with Q7TN58
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| endoplasmic reticulum | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
| Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| mechanosensitive ion channel activity | Enables the transmembrane transfer of an ion by a channel that opens in response to a mechanical stress. |
| protein sequestering activity | Binding to a protein to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active. |
| tumor necrosis factor binding | Binding to tumor necrosis factor, a proinflammatory cytokine produced by monocytes and macrophages. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of protein binding | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| negative regulation of protein-containing complex assembly | Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly. |
| regulation of cell growth | Any process that modulates the frequency, rate, extent or direction of cell growth. |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
| zinc ion homeostasis | Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell. |
3 homologous proteins in AiPD
| 10 | 20 | 30 | 40 | 50 | 60 |
| MFRQWSVQSG | PAPRRPESQA | ASEELWEQEV | ERLCASRTPV | RMLPYAMADK | RFIRELREPE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GVKTTFWQRW | HRPRRVARQH | LREAEQRLAR | GFGLWEGALY | EIGGLFGTGI | QSYFTFLRFL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LLLNLLTMLL | TACFVLLPLV | WLRPPELGPA | LKLRLQCSSS | PLPQSDIPRF | HNPLWNILTG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RAFNNTYLFY | GAYRAGPESS | SEYSIRLAYL | LSPMVCLLLC | FCGILQRMAE | GLPQQTLLGQ |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RYRTPLSAKV | FSSWDFCIRV | WEAATIKKHE | ISNELKMELE | EGRRVELAQQ | QTRAQKACRL |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LTYLRTNILI | VLLVVGAISA | IFWATKYSQD | NKEESLFLVL | QYLPPGVISL | VNFLGPQLFT |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VLIQLENYPP | GTEVNLTLIW | CVVLKLASLG | MFSFSLGQTV | LCIGRNKTSC | ESYGYNACDY |
| 430 | 440 | 450 | 460 | 470 | 480 |
| QCWENSVGEE | LYKLIIFNFL | LTVAFAFLVS | LPRRLLVERF | SGWFWTWLDR | EEFLVPKNVL |
| 490 | 500 | 510 | 520 | 530 | 540 |
| DIVAAQTVTW | MGLFYCPLLP | LLNSVFLFLT | FYIKKYTLLR | NSRASPRRFR | ASSSTFFFHL |
| 550 | 560 | 570 | 580 | 590 | 600 |
| VLLLGLLLAA | VPLAYVISST | HSSWDCGLFT | NYSAPWQVVP | ELVALQLPLP | SQRALRYLSS |
| 610 | 620 | 630 | 640 | 650 | 660 |
| HAFSFPLLIL | LSIVLTVCIS | QSRANARAIQ | GLRKQLVWQV | QEKWHLVDDL | SRLLPELSPE |
| 670 | 680 | 690 | 700 | 710 | 720 |
| PGSPHSRASR | PRSFCPGFPC | PGSPGPRTPR | LAPSNRLSSS | SLGAPSASVP | ASRFHFPSRT |
| EL |